U.S. Department of Health & Human Services

Drug Manufacturer Contacts

Contact details are available for drug companies participating in the Medicaid Drug Rebate Program. Each record includes an optional effective date, a termination date (if applicable), and legal, invoice, and technical contact information.

Example records
Namelegal entityAlternate Namelegal entityCityaddressStateaddressZIP CodeaddressStreet AddressaddressFull NamepersonEmailwebsitePhonephone numberLabeler CoderegistrationOptional Eff. DatetemporalTermination Datetemporal
BAUSCH HEALTH US, LLCBAUSCH HEALTH US, LLCBRIDGEWATERNJ8807400 SOMERSET CORPORATE BLVDSEANA CARSONSEANA.CARSON@BAUSCHHEALTH.COM9056957634992071001199110012025
Zameer Pharmaceuticals LLCZameer Pharmaceuticals LLCIselinNJ883033 Wood Avenue SouthJoel Mittelmanjoel@zameerpharma.com7322109114900963282022
UNITY PHARMAUnity PharmaCovinaCA91723277 E Rowland St,Shabana Yasminshabana@unitypharma.us62653629278427511320257012025
Use cases

Vendor Onboarding Verification for Specialty Pharmacy Networks

A specialty pharmacy or pharmacy benefit manager onboarding a new drug supplier checks whether the manufacturer holds an active Medicaid Drug Rebate Program registration, confirms the labeler code matches FDA records, and validates that the legal entity name and address on file align with the supplier's own documentation before executing a contract.

NameLabeler CodeActive IndicatorStreet AddressOptional Eff. Date

Rebate Processor Identity Mapping for Accounts Receivable Teams

A state Medicaid agency or managed care organization reconciling outstanding drug rebate payments identifies which third-party rebate processing firms are handling invoices on behalf of manufacturers, maps the correct invoice contact and address for each labeler, and flags cases where the invoicing entity differs from the registered manufacturer to prevent misdirected payments.

NameLabeler CodeInvoice Corp.Invoice ContactInvoice Email

Market Exit Detection for Pharmaceutical Sales Intelligence

A market analytics firm tracking competitive dynamics in the generic or specialty drug market monitors termination dates and active status changes to identify manufacturers that have recently exited the Medicaid channel, which can signal product discontinuation, acquisition, or financial distress before those events appear in public filings.

NameLabeler CodeActive IndicatorTermination DateOptional Eff. Date